COMPANY
FDA-approved therapeutic company
Location: Deer Park, IL · source · Oct 14, 2026
Profile checked Oct 10, 2026
Timeline
- FDA FDA Original approval: DESMODA (desmopressin acetate) — NDA219873, Feb 25, 2026. Applicant at approval: Eton Pharmaceuticals, Inc. source ↗
- FDA FDA Original approval: KHINDIVI (hydrocortisone) — NDA218980, May 28, 2025. Applicant at approval: Eton Pharmaceuticals, Inc. source ↗
- Partnership Partnership / licensing announced Apr 1, 2025. Source: SEC filing. source ↗
Funding
Last 2 years.
- Partnership / licensing announced Apr 1, 2025. Source: SEC filing. source ↗
FDA records (last 2 years)
- FDA Original approval: DESMODA (desmopressin acetate) — NDA219873, Feb 25, 2026. Applicant at approval: Eton Pharmaceuticals, Inc. source ↗
- FDA Original approval: KHINDIVI (hydrocortisone) — NDA218980, May 28, 2025. Applicant at approval: Eton Pharmaceuticals, Inc. source ↗
Connect
See your connections at Eton Pharmaceuticals on LinkedIn (search by name, results not checked)LinkedIn shows your 1st and 2nd-degree connections here from your own login, including who could introduce you. Radar doesn't see your connections.
LinkedIn page linked from the company's own site: source · seen 2026-10-12
